The differences between depressive symptoms caused by bipolar disorder and those caused by major depressive disorder (sometimes called "major depression") can be subtle and easy to miss. To be diagnosed with bipolar disorder you must have experienced a high period (mania or hypomania). A manic episode can be the defining criterion that separates a diagnosis of major depressive disorder from bipolar depression. To learn about manic symptoms, click here. That's why it's so important to be familiar with those differences and to have a trusting and open relationship with your health care professional so that you can discuss them. Get more insights on bipolar disorder diagnosis.
Be sure to talk to your health care professional about all the symptoms you are experiencing, including any manic episodes. Health care professionals are trained to recognize the differences between these often-similar disorders, but their ability to do so relies in part on good information and history from you. Use the questions to ask your doctor
at your next appointment. Keep accurate records and notes so that you can have a productive conversation with your health care professional. Consider a Mood Tracking Diary to help you keep track of your symptoms.
SEROQUEL XR is not approved to treat major depressive disorder. SEROQUEL XR is a once-daily tablet approved to treat acute depressive episodes in bipolar disorder; acute mania or mixed episodes in bipolar disorder alone or when added to lithium or divalproex; long-term maintenance of bipolar disorder when added to lithium or divalproex; and schizophrenia.
Learn about the symptoms of bipolar disorder, including bipolar depression.
The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about SEROQUEL XR, talk to your doctor or pharmacist. Only you and your health care professional can decide if SEROQUEL XR is right for you.
Important Safety Information and Indications for SEROQUEL XR
Elderly patients with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) treated with this type of medicine are at an increased risk of death, compared to placebo (sugar pill). SEROQUEL XR is not approved for treating these patients.
Antidepressants have increased the risk of suicidal thoughts and actions in some children, teenagers, and young adults. Patients of all ages starting treatment should be watched closely for worsening of depression, suicidal thoughts or actions, unusual changes in behavior, agitation, and irritability. Families and caregivers should watch patients daily and report these symptoms immediately to the physician. SEROQUEL XR is not approved for patients under the age of 18 years.
This is not a complete summary of safety information. Please discuss the full Prescribing Information
with your
health care provider.
Indications
SEROQUEL XR is a once-daily tablet approved to treat acute depressive episodes in bipolar disorder; acute manic or mixed episodes in bipolar disorder alone or when added to lithium or divalproex; and long-term maintenance of bipolar disorder when added to lithium or divalproex.
Click here to see Prescribing Information for SEROQUEL XR, including Boxed Warnings.![]()
Please see the last page of the Prescribing Information for the Medication Guide.![]()
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call
1-800-FDA-1088.
SEROQUEL XR is a registered trademark and Thinking Forward is a trademark of the AstraZeneca group of companies.
© 2009 AstraZeneca Pharmaceuticals LP. All rights reserved. 280285 9/09
Home
About Us
Advertise with Us
Contact Us
Privacy Policy
Terms of Use
Site Map
Disclaimer/Disclosure
Feeds
Download the Psych Central Toolbar
| Chat with a Live Counselor Now
Copyright © 1992-2009 Psych Central. All rights reserved.
Site last updated: 20 Nov 2009
|
|
We comply |

